Literature DB >> 32512528

MiR-384 inhibits proliferation and migration of trophoblast cells via targeting PTBP3.

Wenbo Zhou1, Guangtong She1, Kaiyan Yang1, Bin Zhang1, Jingbing Liu1, Bin Yu2.   

Abstract

Preeclampsia (PE) is one type of hypertension during pregnancy that seriously threatens maternal and infant health. Trophoblast dysfunction, such as decreased proliferation and migration, is closely related to the occurrence and development of PE. MicroRNAs (miRNAs) have been proven to play an important role in many diseases, including PE. miR-384 was reported to play a regulatory role in promoting cell apoptosis and inhibiting proliferation, migration and invasion in a variety of tumors. Previously, we found that miR-384 is upregulated in the placenta and plasma in the context of PE. In this study, we elucidated the function of miR-384 in the trophoblast cell line HTR-8/SVneo and the trophoblastic tumor cell line JEG-3. Cell proliferation and migration were inhibited by miR-384 overexpression but promoted by miR-384 downregulation. Subsequently, polypyrimidine tract-binding protein 3(PTBP3) was found to be a direct target gene of miR-384. PTBP3 was downregulated in placental tissues from PE patients, and a negative correlation was found between PTBP3 and miR-384. Our results suggest that the miR-384/PTBP3 axis plays an important role in regulating trophoblast function during the progression of PE, and these data provide novel insight into the molecular pathogenesis of this disorder.
Copyright © 2020 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MiR-384; MiRNA; PTBP3; Placenta; Preeclampsia

Mesh:

Substances:

Year:  2020        PMID: 32512528     DOI: 10.1016/j.preghy.2020.05.017

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  6 in total

Review 1.  Non-Coding RNAs Regulate Placental Trophoblast Function and Participate in Recurrent Abortion.

Authors:  Xin Chen; Duan-Ying Guo; Tai-Lang Yin; Jing Yang
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

2.  A blood-based miRNA signature for early non-invasive diagnosis of preeclampsia.

Authors:  Siqi Bao; Tong Zhou; Congcong Yan; Jiale Bao; Fan Yang; Shan Chao; Meng Zhou; Zhangye Xu
Journal:  BMC Med       Date:  2022-09-13       Impact factor: 11.150

3.  LINC00240/miR-155 axis regulates function of trophoblasts and M2 macrophage polarization via modulating oxidative stress-induced pyroptosis in preeclampsia.

Authors:  Hai-Ying Wu; Kan Liu; Jing-Li Zhang
Journal:  Mol Med       Date:  2022-09-24       Impact factor: 6.376

Review 4.  Role of microRNAs in trophoblast invasion and spiral artery remodeling: Implications for preeclampsia.

Authors:  Heyam Hayder; Yanan Shan; Yan Chen; Jacob Anderson O'Brien; Chun Peng
Journal:  Front Cell Dev Biol       Date:  2022-10-03

Review 5.  Roles of noncoding RNAs in preeclampsia.

Authors:  Ningxia Sun; Shiting Qin; Lu Zhang; Shiguo Liu
Journal:  Reprod Biol Endocrinol       Date:  2021-07-02       Impact factor: 5.211

6.  Bioinformatics Analysis of Choriocarcinoma-Related MicroRNA-Transcription Factor-Target Gene Regulatory Networks and Validation of Key miRNAs.

Authors:  Xiaotong Peng; Zhirong Zhang; Yanqun Mo; Junliang Liu; Shuo Wang; Huining Liu
Journal:  Onco Targets Ther       Date:  2021-06-29       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.